Skip to main content
GoodRx Guide

Tardive Dyskinesia: Your GoodRx Guide

Comprehensive information for you or a loved one — including treatment options and discounts on popular medications.
Tracy Norfleet, MD, FACPPatricia Pinto-Garcia, MD, MPH
Written by Tracy Norfleet, MD, FACP | Reviewed by Patricia Pinto-Garcia, MD, MPH
Published on June 1, 2023

Definition

Tardive dyskinesia is a movement disorder. The word “tardive” means “occurring later,” and “dyskinesia” means “abnormal movements.”

People with tardive dyskinesia develop uncontrollable movements after taking certain medications. These medications block a chemical in the brain called dopamine. Dopamine plays an important role in controlling body movements. 

Any drug that blocks the effects of dopamine can cause tardive dyskinesia. It can take months or years for people to develop tardive dyskinesia when taking these medications. 


Causes

Dopamine-blocking medications trigger tardive dyskinesia.

Antipsychotic medications are one of the most common triggers of tardive dyskinesia. They treat schizophrenia, bipolar disorder, and depression. Antipsychotic medications that are more likely to trigger tardive dyskinesia include:

Other medications that can trigger tardive dyskinesia include some:

  • Antinausea medications

  • Antiseizure medications 

  • Antidepressant medications

  • Antimalarial medications


Symptoms

Tardive dyskinesia causes repetitive movements that are difficult or impossible to control. Movements may be mild or so severe that they interfere with everyday activities

Tardive dyskinesia can affect the:

  • Face and mouth: People may experience twitching, frowning, chewing, lip puckering, eye blinking, and tongue thrusting. 

  • Torso: People may experience rocking of the body from side to side or pelvic thrusting. People may also breathe too fast or have trouble breathing.

  • Limbs: People may experience arm swinging and uncontrollable toe or finger movement.


Tardive Dyskinesia Medications

Compare prices and information on the most popular Tardive Dyskinesia medications.

  • Austedo XR
    $3,068.92
    $2,539.63
  • Austedo
    $6,692.53
    $4,931.54
  • Ingrezza Sprinkle
    $10,244.99
    $8,123.45

Diagnosis

There are no blood tests or imaging studies for tardive dyskinesia. 

A healthcare provider can diagnose tardive dyskinesia based on your symptoms. They may also use the Abnormal Involuntary Movement Scale (AIMS) to score your movements. Movements can be scored as 0 (none), 1 (minimal), 2 (mild), 3 (moderate), or 4 (severe). 

Movements rated as 2 or higher suggest tardive dyskinesia


Treatment

There’s no cure for tardive dyskinesia. But with treatment, movements can get better or disappear. 

There are two FDA-approved medications for treating tardive dyskinesia:

These treatments can ease movements and even help some people go into remission. Tetrabenazine is a similar medication that’s FDA approved to treat Huntington’s chorea, a different movement disorder. It’s sometimes used off label to treat tardive dyskinesia. 

Natural therapies may help ease tardive dyskinesia symptoms in some cases. Some people have found success with:


Prevention

The best way to prevent tardive dyskinesia is to avoid dopamine-blocking medications. But this isn’t an option for some people. 

If you need to take one of these medications, you can lower your risk of developing tardive dyskinesia by:

  • Using the lowest possible dose of your dopamine-blocking medication

  • Using dopamine-blocking medications for the shortest possible time

  • Switching to a medication that’s less likely to trigger tardive dyskinesia


Common concerns

Studies show people are more likely to develop tardive dyskinesia if:

  • They’re older than 60 years.

  • They have diabetes.

  • They have a history of severe symptoms of mental health conditions.

  • They have a history of cognitive impairments.

  • They have ongoing substance misuse.

These things don’t guarantee a person will develop tardive dyskinesia. But people at higher risk should talk with their healthcare provider about ways to lower the chances of developing tardive dyskinesia. 

References

Cloud, L. J., et al. (2014). Tardive dyskinesia: Therapeutic options for an increasingly common disorder. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics.

Jain, R., et al. (2018). Tardive dyskinesia: Recognition, patient assessment, and differential diagnosis. The Journal of Clinical Psychiatry.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.

Newsletter Signup